Within-subject biological variation of glucose and HbA1c in healthy persons and in type 1 diabetes patients

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 9, 2011, Pages 1501-1507

  Carlsen, Siri ^a,b   Petersen, Per Hyltoft ^b   Skeie, Svein ^a,b   Øyvind, Skadberg ^a   Sandberg, Sverre ^b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Adult; Diabetes mellitus type 1; Glucose; HbA1c

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BIOLOGICAL RHYTHM; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; CAPILLARIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; VEINS;

EID: 80052866055     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.233     Document Type: Article

References (39)

1. Pickup JC, Williams, G, editors. Textbook of diabetes, 3rd ed. Oxford: Wiley-Blackwell, 2003.
2. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53. (Pubitemid 41817713)
3. Skeie S, Thue G, Sandberg S. Use and interpretation of HbA1c testing in general practice. Implications for quality of care. Scand J Clin Lab Invest 2000;60:349-56.
4. Fraser CG. Biological variation: from principles to practice. Washington DC: AACC Press, 2001:9-26
5. Fraser CG. The application of theoretical goals based on biological variation data in proficiency testing. Arch Pathol Lab Med 1988;112:404-15.
6. Fraser CG. Biological variation in clinical chemistry. An update: collated data, 1988-1991. Arch Pathol Lab Med 1992; 116:916-23.
7. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59: 491-500. (Pubitemid 30056739)
8. Ricos C. Biological variation and desirable specifications for QC, 2006 update. Available from: http://www.westergard.com/guest32.htm.
9. Sebastian-Gambaro MA, Liron-Hernandez FJ, Fuentes-Arderiu X. Intra- and inter-individual biological variability data bank. Eur J Clin Chem Clin Biochem 1997;35:845-52. (Pubitemid 27510862)
10. Lassen JF, Kjeldsen J, Antonsen S, Hyltoft Petersen P, Brandslund I. Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy. Clin Chem 1995;41:1171-6.
11. Widjaja A, Morris RJ, Levy JC, Frayn KN, Manley SE, Turner RC, et al. Within- and between-subject variation in commonly measured anthropometric and biochemical variables. Clin Chem 1999;45:561-6. (Pubitemid 29165967)
12. Cotlove E, Harris EK, Williams GZ. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 3. Physiological and medical implications. Clin Chem 1970;16:1028-32.
13. Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, et al. Biological variation of glycohemoglobin. Clin Chem 2002;48:1116-8. (Pubitemid 34680915)
14. Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care 1998;21:261-4. (Pubitemid 28079435)
15. Garde AH, Hansen AM, Skovgaard LT, Christensen JM. Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A(1c), IgA, prolactin, and free testosterone in healthy women. Clin Chem 2000;46:551-9. (Pubitemid 30210727)
16. Kolatkar NS, Cembrowski GS, Callahan PL, Etzwiler D. Intensive diabetes management requires very precise testing of glycohemoglobin. Clin Chem 1994;40:1608-10. (Pubitemid 24241159)
17. Jorde R, Sundsfjord J. Intra-individual variability and longitudinal changes in glycaemic control in patients with type 1 diabetes mellitus. Diabet Med 2000;17:451-6. (Pubitemid 30471340)
18. Braga F, Dolci A, Mosca A, Panteghini M. Biological variability of glycated hemoglobin. Clin Chim Acta 2010;411: 1606-10.
19. American Diabetes Association. Standards of medical care in diabetes 2010. Diabetes Care 2010;33(suppl 1):S11-61.
20. Fraser CG, Harris E. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
21. Aarsand AK, Petersen PH, Sandberg S. Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. Clin Chem 2006;52:650-6.
22. Jensen E, Petersen PH, Blaabjerg O, Hegedus L. Biological variation of thyroid autoantibodies and thyroglobulin. Clin Chem Lab Med 2007;45:1058-64. (Pubitemid 47424850)
23. Kringle RO, Bogovich M. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry, 3rd ed. Philadelphia; WB Saunders, 1999:265-309.
24. Bliss, CI. Statistics in biology. New York: McGraw-Hill Book Company, 1967.
25. Burdick, RK, Graybill FA. Confidence intervals on variance components. Statistics: Textbooks and monographs, Vol. 127. New York: Marcel Dekker Inc, 1992.
26. Solvik UO, Petersen PH, Monsen G, Stavelin AV, Sandberg S. Discrepancies in international normalized ratio results between instruments: a model to split the variation into subcomponents. Clin Chem 2010;56:1618-26.
27. Harris EK, Yasaka T. On the calculation of a ''reference change'' for comparing two consecutive measurements. Clin Chem 1983;29:25-30. (Pubitemid 13167613)
28. Gowans EMS, Hyltoft Petersen P, Blaabjerg O, Hørder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988;48:757-64. (Pubitemid 19005823)
29. Hyltoft Petersen P, Ricós C, Stöckl D, Libeer J-C, Baadenhuijsen H, Fraser CG, et al. Proposed guidelines for the internal quality control of analytical results in the medical laboratory. Discussion paper from the members of the external quality assessment (EQA) working group A on the analytical quality goals in laboratory medicine. Eur J Clin Chem Clin Biochem 1996;34:983-99.
30. Derr R, Garrett E, Stacy GA, Saudek CD. Is HbA(1c) affected by glycemic instability? Diabetes Care 2003;26:2728-33.
31. Moberg E, Kollind M, Lins PE, Adamson U. Acute mental stress impairs insulin sensitivity in IDDM patients. Diabetologia 1994;37:247-51. (Pubitemid 24076075)
32. Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, et al. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet 1981;2: 1363-5. (Pubitemid 12239439)
33. Faber OK, Binder C. B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment. Diabetologia 1977;13:263-8. (Pubitemid 8109393)
34. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. J Clin Endocrinol Metab 1987;65:30-6.
35. Queralto JM. Intraindividual reference values. Clin Chem Lab Med 2004;42:765-77. (Pubitemid 39137226)
36. Christensen NG. Which HbA1c methods are good (enough). Bioingeniøren 2011;2:20-4.
37. Association AD. Self-monitoring of blood glucose. Diabetes Care 1996;19(suppl 1):S62-6.
38. International Organization for Standardization. ISO 15189 Medical laboratories - particular requirements for quality and competence, 2nd ed. Geneva, Switzerland: international Organization for Standardization, 2007. 48 pages.
39. Arabedjief D, Nichols JH. Assessing glucose meter accuracy. Curr Med Res Opin 2006;22:2167-74. (Pubitemid 44789981)